Advances in Alzheimer's Disease

Share this article:
Advances in Alzheimer's Disease
Advances in Alzheimer's Disease

PROGRAM DESCRIPTION

The National Institutes of Health (NIH) recently funded an exhaustive review by the Agency for Healthcare Research and Quality (AHRQ), performed through its Evidence-Based Practice Centers. This review highlights the presence of critical gaps in current knowledge about Alzheimer's disease (AD) and the progression of cognitive impairment. In addition to recommending continued research into the science of AD, the review emphasized the need for education to the clinicians who treat individuals with dementia to translate the latest research and emerging therapies into meaningful, clinical approaches. The recently published fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has modified and enhanced the way clinicians will describe dementia and emphasizes the need for earlier assessment of neurocognitive disorders.

This neuroscienceCME SnackTM explores the current and emerging science in the management of individuals with AD and challenges clinicians to keep up-to-date on differential diagnosis (e.g., MCI and AD) and offer the best, evidence-based care for their patients with AD.

This is a 30-minute webcast where participants are eligible for 0.5 of a continuing education credit.

ACTIVITY GOAL

This educational activity centers on the CMEO Make One Change Statement. This statement is crafted from pertinent quality measures or clinical guidelines as a performance challenge to all participants. The Make One Change Statement for this activity is: 

Clinicians will use the new diagnostic language in routine clinical practice and will implement routine screening for cognitive impairment for early identification and clinical management of patients with Alzheimer's disease.

INTENDED AUDIENCE

Physicians, pharmacists, and other healthcare professionals who manage patients with Alzheimer's disease.

 

To take this course, go to mycme.com. The log-in information for myCME is the same as McKnight's. Please note that you will need to complete additional registration information. 

Share this article:

Don't miss any McKnight's news

More in CME/CE

The Safe Use of Opioids in the Treatment of Pain

The Safe Use of Opioids in the Treatment ...

This activity has been designed to meet the educational needs of primary-care physicians, physician assistants, and nurse practitioners who treat patients with substance use disorder. It explores the safe use ...

Management of Diabetes in the Long-Term Care Setting

Management of Diabetes in the Long-Term Care Setting

This CME, CNE and ACPE accredited activity will help improve your knowledge of the treatment of diabetes mellitus and improve the quality of care for older adult patients in the ...

Updates on the Diagnosis and Management of Alzheimer's Disease: Screening, Imaging, and Emerging Treatment Strategies

Updates on the Diagnosis and Management of Alzheimer's ...

Alzheimer's disease is the most common form of dementia, affecting approximately 6% to 7% of the population over 65 years of age. The multifactorial etiology of Alzheimer's disease involves complex ...